Cargando…

Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia

Gene or cell therapy is currently not fully efficacious for arteriosclerosis obliterans (ASO). In this study, we determined whether YS-1402, a slow-release synthetic prostacyclin agonist, promoted neovascularization and skeletal muscle regeneration in a mouse model of critical limb ischemia (CLI). W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagawa, Takaya, Miyagawa, Shigeru, Shibuya, Takashi, Sakai, Yoshiki, Harada, Akima, Watanabe, Kenichi, Sawa, Yoshiki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321796/ https://www.ncbi.nlm.nih.gov/pubmed/32637444 http://dx.doi.org/10.1016/j.omtm.2020.05.022

Ejemplares similares

Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
por: Masada, Kenta, et al.
Publicado: (2020)

Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia
por: Umeda, Satoshi, et al.
Publicado: (2016)

Combined administration of laminin-221 and prostacyclin agonist enhances endogenous cardiac repair in an acute infarct rat heart
por: Sougawa, Nagako, et al.
Publicado: (2021)

A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
por: Fukushima, Satsuki, et al.
Publicado: (2015)

Prostacyclin Analogue–Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats
por: Yajima, Shin, et al.
Publicado: (2019)

Notch signaling-modified mesenchymal stem cells improve tissue perfusion by induction of arteriogenesis in a rat hindlimb ischemia model
por: Maeda, Shusaku, et al.
Publicado: (2021)

Engineered clustered myoblast cell injection augments angiogenesis and muscle regeneration in peripheral artery disease
por: Miyake, Keisuke, et al.
Publicado: (2022)

Enhanced myocardial blood flow in ischemic cardiomyopathy by a slow-release synthetic prostacyclin agonist combined with coronary artery bypass grafting: The first human study in a Phase I/IIa clinical trial
por: Kawamura, Takuji, et al.
Publicado: (2023)

Intravenous infusion of bone marrow-derived mesenchymal stem cells improves tissue perfusion in a rat hindlimb ischemia model
por: Maeda, Shusaku, et al.
Publicado: (2022)

Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice
por: Imanishi, Yukiko, et al.
Publicado: (2013)

New cell delivery system CellSaic with adipose-derived stromal cells promotes functional angiogenesis in critical limb ischemia model mice
por: Tanioka, Hideki, et al.
Publicado: (2021)

Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model
por: Iseoka, Hiroko, et al.
Publicado: (2020)

Autologous skeletal myoblast patch implantation prevents the deterioration of myocardial ischemia and right heart dysfunction in a pressure-overloaded right heart porcine model
por: Araki, Kanta, et al.
Publicado: (2021)

Notch Signaling-Modified Mesenchymal Stem Cell Patch Improves Left Ventricular Function via Arteriogenesis Induction in a Rat Myocardial Infarction Model
por: Maeda, Shusaku, et al.
Publicado: (2023)

Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis
por: Tada, Satoru, et al.
Publicado: (2019)

Development of a drug screening system using three-dimensional cardiac tissues containing multiple cell types
por: Takeda, Maki, et al.
Publicado: (2021)

Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model
por: Ito, Emiko, et al.
Publicado: (2023)

Functional and pathological characteristics of reversible remodeling in a canine right ventricle in response to volume overloading and volume unloading
por: Ishimaru, Kazuhiko, et al.
Publicado: (2014)

High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells
por: Goto, Takasumi, et al.
Publicado: (2020)

Tissue Sheet Engineered Using Human Umbilical Cord-Derived Mesenchymal Stem Cells Improves Diabetic Wound Healing
por: Zhang, Jingbo, et al.
Publicado: (2022)

Innovative therapeutic strategy using prostaglandin I(2) agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension
por: Kanaya, Tomomitsu, et al.
Publicado: (2021)

An Infected Popliteal Aneurysm Simultaneously Treated with Resection and Revascularization
por: Nakagawa, Takaya, et al.
Publicado: (2019)

Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy
por: Sawa, Yoshiki, et al.
Publicado: (2013)

Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction
por: Ishida, Masaru, et al.
Publicado: (2019)

Intravital imaging with two-photon microscopy reveals cellular dynamics in the ischeamia-reperfused rat heart
por: Matsuura, Ryohei, et al.
Publicado: (2018)

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
por: Sougawa, Nagako, et al.
Publicado: (2018)

Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice
por: Kashiyama, Noriyuki, et al.
Publicado: (2016)

Influence of coronary architecture on the variability in myocardial infarction induced by coronary ligation in rats
por: Kainuma, Satoshi, et al.
Publicado: (2017)

Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts
por: Kashiyama, Noriyuki, et al.
Publicado: (2019)

Engineered three-dimensional cardiac tissues maturing in a rotating wall vessel bioreactor remodel diseased hearts in rats with myocardial infarction
por: Nakazato, Taro, et al.
Publicado: (2022)

Activated Protein C Has a Protective Effect against Myocardial I/R Injury by Improvement of Endothelial Function and Activation of AKT1
por: Maehata, Yoshito, et al.
Publicado: (2012)

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
por: Iseoka, Hiroko, et al.
Publicado: (2018)

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
por: Ito, Emiko, et al.
Publicado: (2019)

Diverse effects of prostacyclin on angiogenesis-related processes in the porcine endometrium
por: Szymanska, Magdalena, et al.
Publicado: (2023)

Successful Simultaneous Revascularization for Acute Limb Ischemia and Concomitant Acute Myocardial Infarction
por: Miyake, Keisuke, et al.
Publicado: (2018)

Hepatic ischemia-reperfusion syndrome and its effect on the cardiovascular system: The role of treprostinil, a synthetic prostacyclin analog
por: Mouratidou, Christina, et al.
Publicado: (2023)

Dalteparin reduces ischemia/reperfusion-induced liver injury in rats by increasing the hepatic tissue level of prostacyclin
por: Uchiba, M, et al.
Publicado: (2003)

Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells
por: Takeda, Maki, et al.
Publicado: (2018)

Effectiveness and Minimal-Invasiveness of Zone 0 Landing Thoracic Endovascular Aortic Repair Using Branched Endograft
por: Kudo, Tomoaki, et al.
Publicado: (2022)

Assessment of the Effectiveness of Zone 1-Landing Hybrid TEVAR by Comparing Its Outcomes with Those of Zone 2-Landing Hybrid TEVAR
por: Kudo, Tomoaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o6eqmt4bb1dpcbji6fo168if3i